Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors
Rani K. Powers(University of Colorado Anschutz Medical Campus), Joaquı́n M. Espinosa(University of Colorado Anschutz Medical Campus)
Cited by 5
Related Papers
Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program
|Genes & Development|2006|267
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity
|Genome Research|2017|172
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors
|Nature Communications|2019|143
FAM193A is a positive regulator of p53 activity
|Cell Reports|2023|7
The COVIDome Explorer Researcher Portal
|medRxiv|2021|3